Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
Nucleosides & Nucleotides|August 26, 1998
A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonistsM de Zwart, R Link, J K von Frijtag Drabbe Künzel, et al.Journal of Medicinal Chemistry|January 31, 1997
5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazinesW Kuipers, C G Kruse, I van Wijngaarden, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 7, 1998
Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effectsE A van Schaick, C Kulkarni, J K von Frijtag Drabbe Künzel, et al.The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivoE A Van Schaick, R A Math-ot, J M Gubbens-Stibbe, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1995
Suramin analogs, divalent cations and ATP gamma S as inhibitors of ecto-ATPaseM W Beukers, C J Kerkhof, M A van Rhee, et al.Journal of Medicinal Chemistry|March 23, 2001
Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonistsJ E van Muijlwijk-Koezen, H Timmerman, R C Vollinga, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1994
Partial agonism of theophylline-7-riboside on adenosine receptorsA P IJzerman, E M van der Wenden, J K von Frijtag Drabbe Künzel, et al.Journal of Medicinal Chemistry|August 25, 2001
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptorsE W van Tilburg, P A van der Klein, J von Frijtag Drabbe Künzel, et al.Journal of Medicinal Chemistry|July 21, 1998
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypesY C Kim, M de Zwart, L Chang, et al.Molecular Pharmacology|June 1, 1994
A binding site model and structure-activity relationships for the rat A3 adenosine receptorP J van Galen, A H van Bergen, C Gallo-Rodriguez, et al.Pageof 14